Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › STK4 inhibitors for treatment of hematologic malignancies

STK4 inhibitors for treatment of hematologic malignancies

US Patent 10710978 · Granted Jul 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

USP7 inhibition2025
Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 2025
Potent and selective azaindole inhibitors of CDK8 and CDK192025
Bicyclic urea kinase inhibitors and uses thereof2025
Allosteric EGFR inhibitors and methods of use thereof2025
Allosteric EGFR inhibitors and methods of use thereof2025
Small molecule inhibitors of SRC tyrosine kinase2025
Degraders that target proteins via KEAP12025
Small-molecule focal adhesion kinase (FAK) inhibitors2025
Degradation of bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors w2025
Pyrimidines as EGFR-inhibitors and methods of treating disorders2025
Cyclin-dependent kinase degraders and methods of use2025